Late Subclinical Cardiovascular Disease in Testicular Cancer Survivors
Recruiting
Observational Study
Testicular Cancer
Survivorship
ASCVD
Coronary Artery Disease
Lipid Disorder
Hypogonadism, Male
Cisplatin Adverse Reaction
Bone Marrow Transplant Complications
No Placebo Group
Every participant receives an active treatment — no one gets a placebo.
No Study Drug
Researchers observe your health over time — no experimental treatment is given.
At a Glance
- Age
- 18 – 99
- Sex
- Male
- Study type
- Observational
- Participants needed
- 150 (estimated)
- Sponsor
- Indiana University · Other
Think this trial could be right for you?
Answer a few quick questions to see if you may meet the eligibility requirements.
Check Your Eligibility
About This Trial
Late subclinical cardiovascular disease in testicular cancer survivors exposed to cisplatin-based chemotherapy and bone marrow transplant
Trial Locations
Loading…
Loading trial locations…
Eligibility Criteria
Inclusion Criteria
* Patients \>18 years of age
* Patients will be recruited only if cancer-free at clinical evaluation time.
* For the cases a confirmed TC diagnosis who received one or more cycles of CBCT-based chemotherapies (CBCT group, Arm 2)
* For the cases with a confirmed TC diagnosis who r…
Contacts